The extravascular ICD: Evolving paradigms in sudden death prevention

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden cardiac death (SCD) from ventricular arrhythmias.
• Traditional ICDs involve transvenous, subcutaneous, or epicardial lead placements.
• Transvenous leads carry risks of complications.

Purpose of the Study:

• To review the extravascular ICD (EV-ICD) system.
• To synthesize evidence on EV-ICD performance and safety.
• To evaluate the EV-ICD's role in current arrhythmia management.

Main Methods:

• Review of published clinical trials and real-world data on the EV-ICD system.
• Analysis of defibrillation success, pacing capabilities, and complication rates.
• Evaluation of patient selection criteria and device limitations.

Main Results:

• EV-ICD demonstrates high defibrillation success rates.
• Effective antitachycardia pacing (ATP) capabilities were observed.
• Low rates of device-related complications were reported.

Conclusions:

• EV-ICD is a viable option for patients at risk of SCD, especially those unsuitable for transvenous leads.
• It offers an alternative for patients without prior sternotomy or pacing needs.
• Further research is required to establish long-term outcomes and optimize patient selection.